Astrazeneca stock price in gbp

AstraZeneca, 5.75% 13nov2031, GBP, еurobond information: issuer, comment, quotes, payment, ratings. Indicative price is used to calculate the effective yield, duration, modified duration and is calculated Stock exchange and OTC quotes   The Financial Times Stock Exchange 100 Index, also called the FTSE 100 Index, FTSE 100, on the London Stock Exchange with a Sterling or Euro denominated price on the Stock AstraZeneca, AZN, Pharmaceuticals & Biotechnology. 14 Feb 2020 Take a position on over 12,000 shares. Get low margins when you go long or short on global stocks. Low currency conversion fee. 23 Dec 2019 At the time of writing, the stock price has been reported to be 20.95 per cent at a value of GBP 4.100 billion in relation to the present market price of the AstraZeneca Plc's price of the stock was at GBX 7792.00 per stock on  28 Apr 2014 The cash and shares deal would represent a 30 percent premium on AstraZeneca's closing share price of 35.26 pounds on Jan. 3, the closing 

Astrazeneca Plc Ads Stock Quote: AZN Stock News, Quotes ...

AZN | Complete AstraZeneca PLC stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. AstraZeneca PLC AZN(London Stock Exchange) Deutsche Bank today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and cut its price target to 8300p (from 8400p). Transaction: 19429 shares at 0 GBP per share. Today's buy and sell prices Shares in issue, 1,312.23m AstraZeneca plc is a global, science-led biopharmaceutical company that focuses on the discovery,  Получите подробную информацию о акциях AstraZeneca PLC (AZN) включая Цену, Графики, Лондон, 7.144,0, 0,0, 0,0, 2.118.691, +2,35%, GBP, 03/04.

AZN Stock Price, Forecast & News (AstraZeneca) | MarketBeat

It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Price/Cash Flow: Latest closing price divided by the last 12 months revenue/cash flow per share. What next for the AstraZeneca share price? - The Motley ... The pharmaceutical giant AstraZeneca saw some strong results last week, helping to boost its share price toward record highs. As a contrarian investor, I generally see this as a big no-no for